BCAL Diagnostics Limited (BDX) is an Australian company focused on research into the development and commercialisation of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer.BCAL has made significant progress towards commercial development, and ultimately sales, of its blood-based breast cancer test. Company announced it has been issued Trademark Registration for BREASTEST and BCAL Dx in Australia.